(6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione

C36H59N3O7 — CID 167098097

IUPAC(6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione
SMILESCO[C@]1(C)C[C@@H](C)CN(C)C(C2CN(Cc3ccccc3)C2)COC(=O)C(C)(C)C(=O)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O
InChIInChI=1S/C36H59N3O7/c1-23-17-36(6,43-10)32(46-33-30(40)28(37(7)8)16-24(2)45-33)25(3)31(41)35(4,5)34(42)44-22-29(38(9)18-23)27-20-39(21-27)19-26-14-12-11-13-15-26/h11-15,23-25,27-30,32-33,40H,16-22H2,1-10H3/t23-,24-,25+,28+,29?,30-,32-,33+,36-/m1/s1
InChIKeyBWGSKRKKNZANIL-OPNBGCTESA-N
MW645.88 g/mol
LogP3.45
Rot. Bonds7

About (6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione

(6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione (PubChem CID 167098097) has the molecular formula C36H59N3O7 and a molecular weight of 645.88 g/mol. Its IUPAC name is (6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione.

Molecular Properties

Compound Name(6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione
PubChem CID167098097
Molecular FormulaC36H59N3O7
Molecular Weight645.88 g/mol
Exact Mass645.44
IUPAC Name(6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione
SMILESCO[C@]1(C)C[C@@H](C)CN(C)C(C2CN(Cc3ccccc3)C2)COC(=O)C(C)(C)C(=O)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O
InChIInChI=1S/C36H59N3O7/c1-23-17-36(6,43-10)32(46-33-30(40)28(37(7)8)16-24(2)45-33)25(3)31(41)35(4,5)34(42)44-22-29(38(9)18-23)27-20-39(21-27)19-26-14-12-11-13-15-26/h11-15,23-25,27-30,32-33,40H,16-22H2,1-10H3/t23-,24-,25+,28+,29?,30-,32-,33+,36-/m1/s1
InChIKeyBWGSKRKKNZANIL-OPNBGCTESA-N
XLogP3.45
TPSA101.01 Ų
H-Bond Donors1
H-Bond Acceptors10
Rotatable Bonds7
Heavy Atoms46
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500645.88
LogP ≤ 53.45
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze (6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione?
The IUPAC name of (6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione (CID 167098097) is (6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione.
What is the SMILES notation for (6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione?
The canonical SMILES for (6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione is CO[C@]1(C)C[C@@H](C)CN(C)C(C2CN(Cc3ccccc3)C2)COC(=O)C(C)(C)C(=O)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O.
What is the InChIKey of (6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione?
The InChIKey is BWGSKRKKNZANIL-OPNBGCTESA-N. The full InChI is InChI=1S/C36H59N3O7/c1-23-17-36(6,43-10)32(46-33-30(40)28(37(7)8)16-24(2)45-33)25(3)31(41)35(4,5)34(42)44-22-29(38(9)18-23)27-20-39(21-27)19-26-14-12-11-13-15-26/h11-15,23-25,27-30,32-33,40H,16-22H2,1-10H3/t23-,24-,25+,28+,29?,30-,32-,33+,36-/m1/s1.
What are the key properties of (6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione?
(6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione has a molecular weight of 645.88 g/mol, XLogP of 3.45, 7 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (6R,8R,9R,10R)-3-(1-benzylazetidin-3-yl)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-methoxy-4,6,8,10,12,12-hexamethyl-1-oxa-4-azacyclotridecane-11,13-dione is sourced from PubChem (CID 167098097), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).